395 related articles for article (PubMed ID: 10737275)
21. Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study.
Park MS; Perkins SE; Spears GM; Ashrani AA; Leibson CL; Boos CM; Harmsen WS; Jenkins DH; Bailey KR; Ballman KV; Heit JA
Thromb Res; 2016 Aug; 144():40-5. PubMed ID: 27284980
[TBL] [Abstract][Full Text] [Related]
22. Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study.
Heit JA; Lahr BD; Ashrani AA; Petterson TM; Bailey KR
Thromb Res; 2015 Aug; 136(2):298-307. PubMed ID: 26143712
[TBL] [Abstract][Full Text] [Related]
23. Lack of association between airflow limitation and recurrence of venous thromboembolism among cancer patients with pulmonary embolism.
Shin SH; Kang D; Cho J; Chang H; Kim MS; Lee SY; Lee H; Kim H; Kim DK; Kim EK; Park HY
Int J Chron Obstruct Pulmon Dis; 2018; 13():937-943. PubMed ID: 29593386
[TBL] [Abstract][Full Text] [Related]
24. [Risk factors of venous thromboembolism recurrence and the predictive value of simplified pulmonary embolism severity index in medical inpatients].
Shi CL; Zhou HX; Tang YJ; Wang L; Yi Q; Liang ZA
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1112-5. PubMed ID: 27095779
[TBL] [Abstract][Full Text] [Related]
25. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
26. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.
Rézig S; Mao RL; Couturaud F; Lacut K; Delluc A
Thromb Haemost; 2019 Mar; 119(3):490-495. PubMed ID: 30685873
[TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolism following colorectal resection.
El-Dhuwaib Y; Selvasekar C; Corless DJ; Deakin M; Slavin JP
Colorectal Dis; 2017 Apr; 19(4):385-394. PubMed ID: 27654996
[TBL] [Abstract][Full Text] [Related]
28. Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands.
Geersing GJ; Cazemier S; Rutten F; Fitzmaurice DA; Hoes AW
BMJ Open; 2018 Apr; 8(4):e019967. PubMed ID: 29678975
[TBL] [Abstract][Full Text] [Related]
29. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study.
Heit JA; Lahr BD; Petterson TM; Bailey KR; Ashrani AA; Melton LJ
Blood; 2011 Nov; 118(18):4992-9. PubMed ID: 21890644
[TBL] [Abstract][Full Text] [Related]
30. The epidemiology of venous thromboembolism in the community: implications for prevention and management.
Heit JA
J Thromb Thrombolysis; 2006 Feb; 21(1):23-9. PubMed ID: 16475038
[TBL] [Abstract][Full Text] [Related]
31. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism: disease burden, outcomes and risk factors.
Heit JA
J Thromb Haemost; 2005 Aug; 3(8):1611-7. PubMed ID: 16102026
[TBL] [Abstract][Full Text] [Related]
33. The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjögren Syndrome: A General Population-based Study.
Aviña-Zubieta JA; Jansz M; Sayre EC; Choi HK
J Rheumatol; 2017 Aug; 44(8):1184-1189. PubMed ID: 28298559
[TBL] [Abstract][Full Text] [Related]
34. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
35. The occurrence of venous thromboembolism in cancer patients following major surgery.
Toledano TH; Kondal D; Kahn SR; Tagalakis V
Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
[TBL] [Abstract][Full Text] [Related]
36. Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study.
Lin CL; Lin CL; Tzeng SL; Chung WS
Thromb Res; 2017 Jan; 149():70-75. PubMed ID: 27923178
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
38. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?
Áinle FN; Kevane B
Blood Adv; 2020 Nov; 4(21):5595-5606. PubMed ID: 33170937
[TBL] [Abstract][Full Text] [Related]
39. Incidence of venous thromboembolism in hospitalized patients vs community residents.
Heit JA; Melton LJ; Lohse CM; Petterson TM; Silverstein MD; Mohr DN; O'Fallon WM
Mayo Clin Proc; 2001 Nov; 76(11):1102-10. PubMed ID: 11702898
[TBL] [Abstract][Full Text] [Related]
40. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.
Ashrani AA; Barsoum MK; Crusan DJ; Petterson TM; Bailey KR; Heit JA
Thromb Res; 2015 Jun; 135(6):1110-6. PubMed ID: 25891841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
